U
Advantis Corp. ADVT
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

Company Overview

Advantis Corp. (OTC: ADVT) is a U.S.-based holding and development company focused primarily on the cannabis and wellness industries. Public disclosures and OTC market filings indicate that the company has historically operated through subsidiaries involved in cannabis product development, branding, distribution, and retail-oriented consumer products. Its activities have included cannabidiol (CBD) products, ancillary cannabis services, and related wellness offerings targeted at both retail consumers and cannabis industry participants.

The company evolved from a broader corporate structure into a cannabis-focused enterprise during the expansion of state-level cannabis legalization in the United States. Publicly available filings and market disclosures indicate that Advantis pursued growth through brand development, licensing opportunities, and acquisitions or partnerships tied to cannabis-related operations. However, some historical operational details and revenue composition are difficult to independently verify across recent reporting periods, and certain disclosures appear limited compared with larger SEC-reporting issuers. Data inconclusive based on available public sources regarding the scale of current active operations and long-term profitability.

Business Operations

Advantis Corp. has historically generated revenue through cannabis-related consumer products, brand licensing, and subsidiary operations connected to wellness and alternative cannabinoial products. Public filings and OTC disclosures reference activities involving cultivation partnerships, branded products, and distribution relationships tied to the U.S. cannabis market. The company’s operating model appears to rely on intellectual property, product branding, and strategic partnerships rather than large-scale vertically integrated cultivation infrastructure.

Operations have primarily been concentrated in the United States, with exposure to state-regulated cannabis markets rather than broad international expansion. Available disclosures reference subsidiaries and affiliated entities involved in cannabis retail and product commercialization, although the operational status and financial contribution of certain entities are not consistently detailed in recent public filings. The company has historically referenced strategic relationships within the cannabis supply chain, but independently verified information regarding major joint ventures or large institutional partnerships remains limited.

Strategic Position & Investments

Advantis Corp.’s strategic direction has centered on participation in the expanding legal cannabis and wellness sectors, particularly through branded products and niche market positioning. Public statements and investor materials have indicated interest in scaling through acquisitions, licensing arrangements, and product portfolio expansion tied to cannabinoid-based consumer demand. The company has also explored opportunities connected to alternative wellness products and ancillary cannabis services.

Historically referenced subsidiaries and business initiatives have included cannabis consumer brands and distribution-focused operations. Public disclosures indicate that the company has sought to capitalize on evolving state-level legalization trends and increasing acceptance of cannabinoid wellness products. However, compared with larger publicly traded cannabis companies, Advantis remains relatively small in scale, and several announced initiatives have limited independently verifiable operating detail in available public records. Data inconclusive based on available public sources regarding the current materiality of certain investments or subsidiaries.

Geographic Footprint

Advantis Corp. is headquartered in the United States and has primarily focused its operations on domestic cannabis and wellness markets. Public disclosures suggest concentration in U.S. jurisdictions where cannabis and CBD-related activities are permitted under state law. The company’s market presence appears centered on North American consumer demand rather than multinational operations.

There is limited evidence in publicly available filings of significant operational infrastructure outside the United States. While the company has referenced broader market opportunities associated with the global cannabis sector, independently verified information regarding substantial international subsidiaries, manufacturing assets, or foreign operational influence remains limited.

Leadership & Governance

Advantis Corp.’s leadership structure has historically reflected its status as a smaller public company operating in an emerging industry. Governance information available through public filings and OTC disclosures indicates a management team focused on cannabis-sector growth opportunities, strategic partnerships, and corporate restructuring initiatives associated with evolving market conditions.

Key executives and leadership figures identified in public disclosures include:

  • Darren Cherry – Chief Executive Officer
  • Brian Sonneman – Former executive and corporate leadership figure associated with earlier company operations

Public disclosures indicate that leadership strategy has emphasized expansion within legalized cannabis markets, development of consumer-facing cannabis brands, and pursuit of acquisition-driven growth opportunities. However, management composition and governance structures have changed over time, and some executive information varies across historical filings and OTC disclosures.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $218.58
B
AAPL NASDAQ $306.87
B
AVGO NASDAQ $419.42
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $112.51
Top Financial Stocks
See All »
B
B
JPM NYSE $361.48
B
V NYSE $363.34
Top Energy Stocks
See All »
B
ENB NYSE $51.71
B
ENB.TO TSX $71.55
Top Health Care Stocks
See All »
B
LLY NYSE $1,223.91
B
JNJ NYSE $259.04
B
ABBV NYSE $248.01
Top Real Estate Stocks
See All »
B
PLD NYSE $139.10
B
EQIX NASDAQ $1,039.92